{"brief_title": "Study of Duloxetine in Elderly Patients With Major Depressive Disorder", "brief_summary": "A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder", "detailed_description": "Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the acute treatment phase", "condition": "Cognition", "intervention_type": "Drug", "intervention_name": "Placebo", "criteria": "Inclusion Criteria: - You must be able to visit the doctor's office for clinic visits, tests, and procedures. - You must have been diagnosed with major depression, and have had at least one other episode in the past. Exclusion Criteria: - You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder. - You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.", "gender": "All", "minimum_age": "65 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00062673.xml"}